These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 14687831

  • 1. Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?
    Chalasani N, Crabb DW, Cummings OW, Kwo PY, Asghar A, Pandya PK, Considine RV.
    Am J Gastroenterol; 2003 Dec; 98(12):2771-6. PubMed ID: 14687831
    [Abstract] [Full Text] [Related]

  • 2. Serum leptin levels in patients with nonalcoholic steatohepatitis.
    Uygun A, Kadayifci A, Yesilova Z, Erdil A, Yaman H, Saka M, Deveci MS, Bagci S, Gulsen M, Karaeren N, Dagalp K.
    Am J Gastroenterol; 2000 Dec; 95(12):3584-9. PubMed ID: 11151896
    [Abstract] [Full Text] [Related]

  • 3. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.
    Hepatogastroenterology; 1999 Dec; 46(28):2422-5. PubMed ID: 10522010
    [Abstract] [Full Text] [Related]

  • 4. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?
    Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, Liddle C, Samarasinghe D, George J.
    Hepatology; 2002 Aug; 36(2):403-9. PubMed ID: 12143049
    [Abstract] [Full Text] [Related]

  • 5. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K, Szczesniak P, Kumor A, Jasinska A, Omulecka A, Pietruczuk M, Orszulak-Michalak D, Sporny S, Malecka-Panas E.
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [Abstract] [Full Text] [Related]

  • 6. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
    Fujita N, Miyachi H, Tanaka H, Takeo M, Nakagawa N, Kobayashi Y, Iwasa M, Watanabe S, Takei Y.
    Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
    [Abstract] [Full Text] [Related]

  • 7. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
    Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, Pacini G, De Michieli F, Rabbione L, Premoli A, Cassader M, Pagano G.
    Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO, Park SH, Park CH, Han TH, Yoo KS, Kim JH, Lee MS, Kim DJ, Park CK, Cho HD.
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [Abstract] [Full Text] [Related]

  • 9. Increased expression of Ob-Rb and its relationship with the overexpression of TGF-beta1 and the stage of fibrosis in patients with nonalcoholic steatohepatitis.
    Cayón A, Crespo J, Mayorga M, Guerra A, Pons-Romero F.
    Liver Int; 2006 Nov; 26(9):1065-71. PubMed ID: 17032406
    [Abstract] [Full Text] [Related]

  • 10. Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophy.
    Javor ED, Ghany MG, Cochran EK, Oral EA, DePaoli AM, Premkumar A, Kleiner DE, Gorden P.
    Hepatology; 2005 Apr; 41(4):753-60. PubMed ID: 15791619
    [Abstract] [Full Text] [Related]

  • 11. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.
    Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Jun; 103(6):1372-9. PubMed ID: 18510618
    [Abstract] [Full Text] [Related]

  • 12. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 13. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A, Gowder SJ, Schlauch K, Elariny H, Collantes R, Afendy A, Ong JP, Goodman Z, Chandhoke V, Younossi ZM.
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [Abstract] [Full Text] [Related]

  • 14. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
    Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J.
    Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
    [Abstract] [Full Text] [Related]

  • 15. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E, Strasser M, Haufe H, Sonnweber T, Hohla F, Stadlmayr A, Solioz M, Tilg H, Patsch W, Weiss G, Stickel F, Datz C.
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [Abstract] [Full Text] [Related]

  • 16. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL, Lee WJ, Lee YC, Wang HH, Wang W, Lin YC.
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [Abstract] [Full Text] [Related]

  • 17. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S, Yukawa T, Uetake S, Yamauchi M.
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [Abstract] [Full Text] [Related]

  • 18. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP.
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [Abstract] [Full Text] [Related]

  • 19. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ.
    Scand J Gastroenterol; 2008 Feb; 43(9):1128-36. PubMed ID: 18609175
    [Abstract] [Full Text] [Related]

  • 20. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
    Konopelska S, Kienitz T, Hughes B, Pirlich M, Bauditz J, Lochs H, Strasburger CJ, Stewart PM, Quinkler M.
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.